Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: The MIR RCT
(2018)
Journal Article
Kessler, D., Burns, A., Tallon, D., Lewis, G., Macneill, S., Round, J., Hollingworth, W., Chew-Graham, C., Anderson, I., Campbell, J., Dickens, C., Macleod, U., Gilbody, S., Davies, S., Peters, T. J., & Wiles, N. (2018). Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: The MIR RCT. Health Technology Assessment, 22(63), 1-136. https://doi.org/10.3310/hta22630
Background: Depression is usually managed in primary care and antidepressants are often the first-line treatment, but only half of those treated respond to a single antidepressant.
Objectives: To investigate whether or not combining mirtazapine wit...
Read More about Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: The MIR RCT.